INS and Hypoglycemia: Insulin preparation formulation type can influence the risk of infusion set failure;36 however, results of the 6‐week onset 4 trial indicated a similar compatibility of faster aspart and IAsp with CSII.37 No microscopically‐confirmed infusion set occlusions were observed for faster aspart or IAsp and, after adjusting for an imbalance during the run‐in period, the rate of severe or BG‐confirmed hypoglycaemia was similar for both insulins.